- Raised $10M funding round, Nov 2011
About
Arineta develops and produces cardiovascular imaging solutions. Arineta's flagship product is CardioGraphe, a dedicated single-heartbeat, whole-heart cardiac CT scanner based on the company's proprietary Stereo CT technology. CardioGraphe is designed to provide comprehensive clinical information for diagnosis and therapy planning. It is optimized for imaging the entire heart and cardiovascular system with 140-mm coverage at a rotation speed of 0.24 seconds per rotation. The system uses a lower radiation dose than whole-body CT scanners. Further, the imaging based on a single heartbeat and the fast speed of the scan reduce contrast volumes and the need for a beta blocker. Clinical applications from calcium scoring to cardiac CTA and peripheral vascular imaging can be executed easily and successfully even for obese patients or those with high or unstable heart rates. CardioGraphe is distributed globally by GE Healthcare. The product has regulatory clearance in the United States, Canada, European Union, and other regions. It is installed and operates successfully in hospitals in North America, Europe, China, and Israel.
Funding history · 1 round · $10.0M total
Q&A
- What is Arineta's primary focus?
- Arineta specializes in developing and producing cardiovascular imaging solutions, with its flagship product being CardioGraphe, a dedicated cardiac CT scanner.
- What is CardioGraphe?
- CardioGraphe is Arineta's proprietary single-heartbeat, whole-heart cardiac CT scanner based on Stereo CT technology, designed for comprehensive clinical information in cardiac diagnosis and therapy planning.
- What are the key features of Arineta's CardioGraphe system?
- CardioGraphe offers 140-mm coverage at a rotation speed of 0.24 seconds per rotation, uses a lower radiation dose than whole-body CT scanners, and reduces contrast volumes and the need for beta blockers.
- Who distributes Arineta's CardioGraphe globally?
- GE Healthcare is the global distributor for Arineta's CardioGraphe product.
- In which regions does CardioGraphe have regulatory clearance and operate?
- CardioGraphe has regulatory clearance in the United States, Canada, European Union, and other regions, and is installed in hospitals in North America, Europe, China, and Israel.
- When was Arineta founded?
- Arineta was founded in June 2006.
- What is the total amount of funding Arineta has raised?
- Arineta has raised a total of $10,000,000 USD.
- When was Arineta's last funding round?
- Arineta's last funding round occurred in November 2011, raising $10,000,000 USD.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | arineta.com |
|---|---|
| linkedin.com/company/9485382 | |
| facebook.com/arinetaltd |
Identifiers & details
| Founded | 2006-6 |
|---|---|
| Employees (exact) | 93 |
Radar intelligence
Patents
| EPO | 21 |
|---|
Publications (Crossref)
| Works | 1 |
|---|
Web history (Wayback)
| Domain | arineta.com |
|---|
Certificate / subdomain footprint
| Subdomains | 7 |
|---|